PressDigest

Valeant closes in on $9.7bn-plus takeover of Salix

Acquisitive Canadian pharmaceuticals company Valeant is on the verge of finalising an agreement to buy US gastrointestinal drug specialist Salix for more than $9.7bn, sources told the Financial Times.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire